Lamivudine Completed Phase 3 Trials for Hepatitis / Hepatitis B Chronic Infection / Liver Cirrhosis Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00076336Telbivudine Versus Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis